Podcasts about health innovation

In this episode of The Health Disparities Podcast, host Ber‑Henda Williams sits down with Dr. Caira Boggs, Director of the Michigan Public Health Institute's Center for Health Innovation and Practice and Detroit Health Initiatives. A proud Detroit native and Detroit Public Schools graduate, Dr. Boggs leads 16 initiatives focused on health equity, recovery, food access, chronic disease prevention, and community‑led grantmaking — all grounded in the lived experiences of Detroit neighborhoods. Dr. Boggs shares the early moments that shaped her understanding of inequity, from growing up in a deeply connected Detroit community to witnessing stark disparities when she left home for college. Her path from kinesiology and pre‑med to public health leadership was fueled by a desire to advocate for people who look like her — especially after learning how maternal and infant health outcomes disproportionately impact Black women, regardless of income or education. Together, Ber‑Henda and Dr. Boggs explore:  What resilience looks like in Detroit neighborhoods, where communities “keep going, keep moving, no matter what,” despite redlining, food insecurity, and structural barriers. How Detroit schools and neighborhood roots shaped Dr. Caira's public health lens. Worker health realities in Detroit's plants — from blood pressure to chronic disease risks. What recovery‑friendly workplaces need: Narcan access, dignity, and long‑term support. Food insecurity as both structural and neighbor‑to‑neighbor — and how small acts help.  Neighborhood‑driven solutions like micro‑grants, walking clubs, and anchor organizations. How COVID‑19 exposed inequities and elevated social determinants of health. Dr. Boggs also reflects on the personal experiences that continue to motivate her — from loved ones whose health outcomes could have been different with better access, to the collective trauma and awakening brought on by the pandemic. Her message is clear: every person has the power to change someone's trajectory, whether through advocacy, compassion, or simply knowing the people on your block. This episode is essential listening for anyone working in community health, public health, philanthropy, health equity, or systems‑level change — and for anyone who believes in the strength and brilliance of Detroit's neighborhoods.

What happens when a lifelong passion for science, innovation, and helping others comes together in one remarkable career? In this episode of The She Believed She Could™ Podcast, Allison Walsh sits down with Dr. Erica Stockwell, an advanced gynecologic surgeon with AdventHealth for Women, to discuss her groundbreaking work in women's healthcare, minimally invasive surgery, and medical innovation. Dr. Stockwell shares how her background in biomedical engineering, medicine, and business led her to become a pioneer in robotic surgery and surgical technology. From holding medical device patents to helping shape the future of AI-assisted healthcare, she offers a fascinating look at where women's health is headed and why innovation matters more than ever. But beyond her impressive accomplishments, Dr. Stockwell also reveals the deeply personal challenges that shaped her journey. During medical residency, she became a new mother while simultaneously caring for her infant daughter battling cancer. Her powerful story of perseverance, faith, and community support serves as a reminder that even the most successful women face valleys—and that resilience is built by continuing forward through them. Together, Allison and Dr. Stockwell explore leadership, confidence, endometriosis care, women's health advocacy, entrepreneurship, motherhood, and the courage it takes to keep believing in yourself when life gets hard. If you're looking for inspiration, practical wisdom, and a glimpse into the future of healthcare, this conversation is one you won't want to miss. What You'll Learn in This Episode: How innovation is reshaping women's healthcare The benefits of minimally invasive gynecologic surgery Emerging trends in robotic surgery and AI-assisted medicine Why endometriosis requires comprehensive, multidisciplinary care How to build resilience during life's hardest seasons The role of mentorship and support systems in success Why confidence is created through action Lessons on leadership, entrepreneurship, and impact How to navigate motherhood while pursuing ambitious goals The future of women's health technology This episode is sponsored by AdventHealth for Women. Learn more about their Women's Health Navigation Team and how they're making healthcare simpler for women and their families at AdventHealthForWomen.com. Positioned for Partnerships™ Mini Course - Turn your platform into a revenue-generating brand opportunity—without needing a massive following. Learn how to position your brand, create a high-converting media kit, and confidently pitch partnerships so brands instantly understand your value. 

For decades, men had Viagra. Women were told to relax and have a glass of wine. That imbalance in pharmaceutical innovation is finally changing, but it hasn't been easy.In this episode, I talk with Sabrina Johnson, the founder and CEO of Dare Bioscience the only publicly traded pharmaceutical company focused entirely on women's healthcare. We discuss why the pharmaceutical industry has historically avoided investing in women's sexual health, the stigma and sexism that surrounds female arousal and pleasure, and what it actually takes to develop and bring products to market.Sabrina walks us through the development of Dare to Play, a topical cream for sexual arousal that's coming soon, the science behind how it works, and the extensive clinical trials required to prove safety and efficacy. We also discuss other products in development a probiotic for vaginal health and a once-a-month vaginal ring for menopause with estradiol and progesterone. This is about changing what's possible for women's health.From regulatory hurdles to cultural stigma, the barriers to innovating in women's sexual health are real. In this conversation, we explore how companies can create real world solutions that actually work for women's lives, the importance of rigorous clinical testing, and why investing in women's health matters. We dive into the science, the business side, and how you can support this work.Highlights:Only 1% of private investment in pharmaceutical development goes to companies innovating solely for women which is why there's so little funding and so many gaps.The stigma is real: one NPR station refused to air an interview because Sabrina said the word "vagina" too many times.Dare to Play increases blood flow to genital tissue for sensation and lubrication the same mechanism as Viagra, but in cream form. The major innovation was developing specialized delivery technology to get sildenafil through skin and manufacturing at pharmaceutical grade standards rather than compounding standards.Dare worked with the SEC and NASDAQ to create a direct public offering so anyone can invest with just $250, not just institutional investors.I hope this episode inspires you to think differently about women's health innovation and what's possible when we demand better. If you believe in the work DARE is doing, you can support it. You don't have to donate you can become an investor with as little as $250. All the information on how to do that will be below.Get in touch with Sabrina:WebsiteBecome an InvestorInstagramLinkedInTikTokGet in Touch with Me:WebsiteInstagramYoutubeSubstack

What happens when you know something is wrong with your body, but no one seems to be listening? In this episode, Stephanie Mitton sits down with award-winning journalist and host of TVO's Mistreated, Nam Kiwanuka, for a powerful conversation about women's health, medical dismissal, and the gaps in research that continue to impact women across Canada and beyond. Nam shares her personal experience navigating fibroids, chronic anemia, lengthy surgical wait times, and the frustration of advocating for care while trying to show up for her family and career. Together, they explore why women's health has been historically under-researched, how lived experience and evidence can work together, and what women can do to advocate for themselves in a complex health care system. This Episode Covers: Nam's personal health journey and the diagnosis that changed everything Why women are often dismissed or misdiagnosed in health care settings The impact of research gaps on conditions like fibroids, endometriosis, ADHD, migraines, and autoimmune diseases How social media can both help and hinder women searching for health information The importance of self-advocacy and knowing your medical history What femtech is and how innovation is helping address women's health challenges Practical ways women can support change in research, policy, and health care Women's health affects every aspect of our lives, from our careers and families to our confidence and wellbeing. This conversation is a reminder that your symptoms matter, your experiences matter, and your voice matters. Whether you're navigating your own health journey or supporting someone you love, you'll leave this episode with greater understanding and practical ways to advocate for better care. https://www.patreon.com/womendontdothat Instagram - http://www.instagram.com/womendontdothat/ TikTok- http://www.tiktok.com/@womendontdothat Blog- https://www.womendontdothat.com/blog Podcast- https://www.womendontdothat.com/podcast Newsletter- https://www.beaconnorthstrategies.com/contactwww.womendontdothat.com YouTube - http://www.youtube.com/@WOMENdontDOthat How to find Stephanie Mitton: Twitter/X- https://twitter.com/StephanieMitton LinkedIn - https://www.linkedin.com/in/stephaniemitton/ beaconnorthstrategies.com TikTok- https://www.tiktok.com/@stephmitton Instagram- https://www.instagram.com/stephaniemitton/ Interested in sponsorship? Contact us at hello@womendontdothat.com Produced by Duke & Castle Our Latest Blog: https://www.womendontdothat.com/post/i-don-t-do-resolutions-i-do-this-perfect-for-busy-women Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, I chat with Gaea. At the tender age of 15, Gaea was forced to give up all that she loved when faced with an unexpected diagnosis of juvenille onset idiopathic rheumatoid arthritis. As a talented runner, Gaea found herself barely even being able to walk and carry out the most basic of daily tasks. But, this story didn't end there. Gaea was not going to let this diagnosis define her. She desired to become a mother and live a full life.This conversation dives deep into the intersection of autoimmunity, motherhood, and natural health innovations. Gaea's honest reflections on managing her condition whilst raising five children will resonate with mothers juggling invisible illnesses and the unspoken struggles of chronic health.Beyond the science, Gaea's insights on emotional resilience, the spiritual side of motherhood, adaptations to the model of 'normal family life' and how self-awareness can bring peace in chaos offer a compelling call to embrace wholeness in all aspects of life. This episode will bring resonance to all mothers, with particular resonance on or women facing autoimmunity, health warriors, and anyone curious about integrative approaches to wellness.This is part one of a two part episode.Please note: The information in this episode is not medical advice. It is based on the experience of one individual. No health claims are made or guaranteed. Please seek advice from your own health care provider before changing any form of treatment plan.https://www.instagram.com/souloasis__/

For twenty years, hearing the patient meant owning a Voice of Customer program. A survey, a tool, a dashboard you showed the board. On May 18, Qualtrics closed its 6.75 billion dollar acquisition of Press Ganey Forsta. The instrument the majority of U.S. hospitals use to hear their patients is now part of a cross-industry experience platform with its own roadmap. Chris Boyer and Reed Smith take that deal apart and ask who, inside the building, still works for the patient once the listening tool belongs to someone else. This is the third Touch Point in a row circling the same observation. TP485 argued digital equity is a clinical operations problem the health system can no longer outsource. TP487 argued the front door moved off the property. TP489 closes the pattern. The listening apparatus moved too. The episode argues marketing should stop being the collector of patient voice and become its advocate. Owning a program means making the signal presentable. Advocacy means being the named person accountable for the patient's voice surviving contact with a budget meeting. That role has a cost, and the episode names it plainly. If your health system would not fund a single internal advocate to carry the patient's voice into the room, you have already priced what that voice is worth to you. Mentions and links: Qualtrics, Qualtrics Acquires Healthcare Experience Leader Press Ganey Forsta for $6.75 Billion, PR Newswire, May 2026: https://www.prnewswire.com/news-releases/qualtrics-acquires-healthcare-experience-leader-press-ganey-forsta-for-6-75-billion-302774876.html Becker's Hospital Review, Qualtrics completes $6.75B deal for Press Ganey, May 2026: https://www.beckershospitalreview.com/digital-health/qualtrics-completes-6-75b-deal-for-press-ganey/ CMSWire, After Uncertainty, Qualtrics Closes Deal on $6.75B Press Ganey Forsta Acquisition, May 2026: https://www.cmswire.com/customer-experience/after-uncertainty-qualtrics-finalizes-6-75-billion-acquisition-of-press-ganey-forsta/ Healthcare IT News, Qualtrics eyes a data engine to predict the experiences patients want, May 2026: https://www.healthcareitnews.com/news/qualtrics-eyes-data-engine-predict-experiences-patients-want AHA Center for Health Innovation, What the Qualtrics Acquisition of Press Ganey Forsta Will Mean for Health Care, October 2025: https://www.aha.org/aha-center-health-innovation-market-scan/2025-10-14-what-qualtrics-acquisition-press-ganey-forsta-will-mean-health-care Qualtrics, Synthetic Data for Market Research FAQ, February 2026: https://www.qualtrics.com/articles/strategy-research/synthetic-data-market-research/ b2b International, AI in Market Research: The Limitations of Synthetic Data, August 2025: https://www.b2binternational.com/publications/ai-in-market-research-the-limitations-of-synthetic-data/ Customer Experience Dive, How synthetic data might shape consumer research, November 2024: https://www.customerexperiencedive.com/news/synthetic-data-consumer-research-customer-journey-qualtrics/732408/ Bain & Company, How Synthetic Customers Bring Companies Closer to the Real Ones, June 2025: https://www.bain.com/insights/how-synthetic-customers-bring-companies-closer-to-the-real-ones/ CMS, HCAHPS: Patients' Perspectives of Care Survey, 2025: https://www.cms.gov/medicare/quality/initiatives/hospital-quality-initiative/hcahps-patients-perspectives-care-survey Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of BioTalk with Rich Bendis, Sam Gussman-Toh, Portfolio Manager for the Small Business Program at ARPA-H, joins the conversation to discuss how the agency is creating new pathways for small businesses developing ambitious health technologies. Sam explains how the ARPA-H model differs from traditional federal funding programs, with a focus on moonshot health solutions, program manager-led portfolios, milestone-driven contracts, and a strong emphasis on moving technologies toward real-world use. He also discusses how the Small Business Program supports SBIR and STTR performers through Phase I, Phase II, Direct to Phase II, and Fast Track awards. The conversation highlights how ARPA-H is working with ambitious small businesses, including non-traditional companies and early-stage startups that may be working with the federal government for the first time. Sam also shares how commercialization support is built into the program, including ARPA-H's Entrepreneur-in-Residence partnership with BioHealth Innovation. Through that relationship, BHI EIRs help performers strengthen regulatory strategy, intellectual property planning, go-to-market strategy, reimbursement considerations, and other key commercialization needs. Sam also discusses ARPA-H's draft Small Business Program solicitation, the upcoming virtual Proposers' Day on June 11, and what companies should know about the application process, topic areas, technical pitches, and future funding opportunities. Editing and post-production work for this episode was provided by The Podcast Consultant. Sam Gussman-Toh is Portfolio Manager for the Small Business Program at ARPA-H, where he coordinates and oversees the agency's SBIR/STTR awards and commercialization support services for participating small businesses. Sam joined ARPA-H in 2022 and wrote the agency's first SBIR/STTR solicitation. He has held several roles in the Office of Commercialization and has worked closely with Program Managers to build the agency's commercialization infrastructure and strategy. Previously, Sam designed and managed rapid prototyping programs across agencies in the Department of War. His technical background is in computer science, with interests in computer vision, autonomous robotic systems, and computational pathology.

This episode features Jeff Marrazzo, Co-Founder of Spark Therapeutics, discussing his journey in human health and entrepreneurship. You'll also learn about the PABC's two new board members: Mark R. Schweiker, former Governor of Pennsylvania, and J. David Owens, biotech entrepreneur and executive. 

//The Wire//2300Z May 12, 2026// //ROUTINE// //BLUF: DETAILS COME TO LIGHT REGARDING YESTERDAY'S FIREFIGHT IN CAMBRIDGE. GLOBAL ENERGY CRISIS GROWS AS MISHAPS AND INDUSTRIAL ACCIDENTS CONTINUE TO IMPACT REFINERIES. CALIFORNIA MAYOR PLEADS GUILTY TO SERVING AS A CHINESE AGENT.// -----BEGIN TEARLINE-----  -International Events-United Kingdom: Over the past few weeks, Prime Minister Starmer has faced growing calls for his resignation, with a total of 90 Labour MPs now openly requesting his resignation. Following the political tensions of the morning, more resignations have taken place, with Shadow Minister for Domestic Violence and Safeguarding Jess Phillips and Under-Secretary of State for Health Innovation and Safety Zubir Ahmed both resigning their posts this morning.Analyst Comment: This tidal wave of dissent from within Starmer's own party is probably a knee-jerk reaction to the devastating election losses over the past few days, in which his political opponents gained significant ground in Parliament. Many Britons have begun to dump the Labour Party for alternate choices due to the social, political, economic, and immigration issues being at a breaking point. PM Starmer has vowed to not step down for the time being, but the political situation remains in the balance as pressure on Starmer's government mounts.Mexico: Overnight a large fire was reported at the Salina Cruz Refinery in Oaxaca. Pemex officials have stated that the fire began inside a cooling tower at the Hidros 2 plant, which was in the process of being brought online to increase production at the facility. The fire was brought under control and extinguished after a few hours, and 6x workers at the refinery were injured as a result of the blaze.-HomeFront-Oklahoma: Yesterday afternoon an explosion was reported at the HF Sinclair Refinery in west Tulsa. The facility was able to contain the spread of the fire, and firefighters extinguished the fire after a few hours. The cause of the incident is not known as the investigation into the incident continues.California: Yesterday the mayor of Arcadia resigned after accepting a deal with the Department of Justice to plead guilty to serving as an unregistered Chinese agent. Mayor Eileen Wang admitted to serving the interests of the Chinese Communist Party, specifically with regards to promoting propaganda efforts directly from the Chinese government. According to the documents provided by the DoJ, Wang was in direct communication with high-ranking Chinese officials and was taking direct orders from leadership in Beijing regarding political decisions that were made by her office. Wang is expected to formally accept the plea deal within the next few weeks.-----END TEARLINE-----Analyst Comments: Yesterday's mass shooter in Cambridge has been identified as Tyler E. Brown, a resident of Boston. Brown has a long criminal history, and has displayed violent intent (just for the sake of violence) for many years. The latest example of this history includes a previous incident that took place under nearly identical circumstances. In 2020, Brown engaged in a shootout with police in Boston in a similar manner to yesterday's skirmish. During that incident six years ago, Brown began harassing and threatening random people on Northampton Street, before engaging police in a gun battle in the street. Brown was eventually wounded and detained, after attempting to kill everyone in his immediate vicinity. In the news articles from that 2020 shooting, Boston Police Commissioner William Gross was quoted as criticizing local judges for letting people like this out of jail and giving them a slap on the wrist, as even in 2020, Brown had been given light sentences for his previous crimes.Nevertheless, Brown was sentenced to only 5 years of prison time by Suffolk Superior Court Judge Janet Sanders, who rejected the recommended 10-12

In this episode of the WHOOP Podcast, WHOOP Founder and CEO Will Ahmed sits down with Quest Diagnostics CEO Jim Davis to discuss the partnership behind WHOOP Advanced Labs. Will and Jim discuss how combining blood biomarkers with continuous physiological data is reshaping consumer health. Will and Jim explore how trends in metrics like cholesterol, glucose, sleep, and recovery can drive more personalized, actionable insights and help shift healthcare from reactive to preventative. Jim shares his personal approach to health tracking, Quest's vision for democratizing lab testing, and leadership lessons from running a 50,000+ employee organization. Jim gets candid about his “obsession” with his WHOOP data and his advice for managing stress and staying focused on long-term health habits.Sign up for WHOOP Advanced Labs, available now in the WHOOP app. Learn more about WHOOP Advanced Labs here.(01:12) Jim Davis on the WHOOP x Quest Diagnostics Partnership(03:06) What WHOOP Members Can Expect From WHOOP Advanced Labs(07:10) Action From Insight: Understanding Trends To Optimize Your Health(12:27) How Frequently Should You Check Your Biomarkers? (13:25) Building The Tech: The Challenges of Health Innovation(18:10) Establishing Wellness Trends: Why Annual Bloodwork Matters(20:41) Lifestyle Factors That Can Cause Issues In Health & Biomarkers(22:23) Growing The Business: Jim's Vision For The Future of Quest(30:25) Do We Need Supplements?: What Your Bloodwork Says About Supplementation(32:37) Jim Davis on Understanding Blood Biomarkers & Using WHOOP To Form Healthy Habits(37:00) Jim's Lessons on Operational ExcellenceSupport the showFollow WHOOP:Sign up for WHOOP Advanced LabsTrial WHOOP for Freewww.whoop.comInstagramTikTokYouTubeXFacebookLinkedInFollow Will Ahmed:InstagramXLinkedInFollow Kristen Holmes:InstagramLinkedInFollow Emily Capodilupo:LinkedIn 

Our coverage of the World Federation of Societies of Anaesthesiologists annual conference begins with an exclusive conversation with this year's recipients of the WFSA Blood Health Innovation Award, Vijay Anand Ismavel and Ann Miriam Devarathnam. Andy Cumpstey finds out about their collaborative project with Kerala Digital University to develop an intraoperative auto-transfusion device, designed to recycle a patient's own blood during surgery in resource-constrained environments. For more information about this device, see: https://jogs.one/icigs_1003_70/ -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - https://ebpom.org/product/ebpom-world-congress-2026/

Clarence Ford speaks to Professor Jeannie van der Linde and Dr Maria du Toit from the University of Pretoria about a new low-cost voice technology that could expand access to vocal health services and enable earlier diagnosis of voice disorders. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk56See omnystudio.com/listener for privacy information.

Five Good Things with Janae Sharp and Megan Antonelli: A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology. Learn about cutting-edge solutions improving patient outcomes Discover how technology is enhancing healthcare accessibility Gain insight into successful digital health implementations Stay informed about positive industry trends shaping the future of care Janae Sharp, Founder, The Sharp Index Megan Antonelli, Founder & CEO, HealthIMPACT

Healing vs Treating: Why Modern Medicine Is About to Change Forever In this conversation with Dr. Elliot Lander, we explore a fundamental shift happening in healthcare—moving from reactive treatment to proactive, regenerative healing. Key Themes & Takeaways: Treatment vs Healing Traditional medicine often focuses on managing symptoms rather than addressing root causes. Dr. Lander explains why this model persists—and where it falls short. The Rise of Regenerative Medicine A new frontier in healthcare is emerging, focused on repairing and restoring damaged tissue rather than replacing or suppressing it. This includes advanced therapies designed to support the body's natural recovery processes. Why the Current System Is Reactive Most healthcare systems are built around disease management, not optimization. We discuss how incentives, education, and infrastructure shape this reality. Personalized Medicine Is the Future No two patients are the same. Genetics, lifestyle, and environment all play a role—making individualized care the next major evolution in medicine. The Mind-Body Connection Healing isn't just physical. Stress, mindset, and emotional health can directly influence recovery, performance, and long-term outcomes. Technology & Innovation From biologics to data-driven diagnostics, emerging technologies are accelerating the shift toward more precise and effective care. Empowering the Patient The future of health isn't passive. Patients who understand their bodies and take an active role in their care will see the greatest benefits.

Janet Hamada Kelley, Executive Director of the Alzheimer's Association San Diego Imperial Chapter, and David Crean, the Alzheimer's Association's Brilliance Gala Chair, discuss brain health, caregiving leadership, and the "Music Meets Memory" innovation transforming dementia care. Discover how philanthropy, research investment, and corporate social impact can change the trajectory of Alzheimer's for local families and workplaces. Listen Where You Live!About Spotlight and Cloudcast Media  "Spotlight On The Community" is the longest running community podcast in the country, continuously hosted by Drew Schlosberg for 20 years.  "Spotlight" is part of Cloudcast Media's line-up of powerful local podcasts, telling the stories, highlighting the people, and celebrating the gravitational power of local.   For more information on Cloudcast and its shows and cities served, please visit www.cloudcastmedia.us. Cloudcast Media | the national leader in local podcasting.   About Mission Fed Credit Union  A community champion for over 60 years, Mission Fed Credit Union with over $6 billion in member assets, is the Sponsor of Spotlight On The Community, helping to curate connectivity, collaboration, and catalytic conversations.  For more information on the many services for San Diego residents, be sure to visit them at https://www.missionfed.com/

Let us know what you think!Doc Springer joins the show for a conversation about suicide prevention, trauma recovery, warrior healing, and why connection is critical for survival.In this episode, we cover:False beliefs about suicide prevention Warrior healing and peer support Innovative biological treatments Mental performance and readiness Building trust in healing relationships Advocating for yourself in mental health care The importance of connection and community Doc Springer's new book, Fallout Resources Mentioned:Fallout Thin Line Advisory Magnus One Task Force Dagger Stella Mental Health Treatments  Chapters:00:00 Why Authentic Healing Conversations Matter 03:02 The Importance of Connection in Warrior Healing 05:58 Doc Springer's Journey into Supporting Warriors 09:00 Why Warriors Need Mental Warfare Preparation 11:55 The Challenges of Transitioning from Combat 15:10 Innovative Treatments for Warrior Mental Health 17:54 Mental Performance and Warrior Readiness 20:49 Breaking Down Barriers to Healing 24:01 A Holistic Approach to Mental Health and Wellness 26:57 Walking Alongside Warriors Through Recovery 32:33 Empowerment, Guidance, and Personal Responsibility 36:11 Recognizing Red Flags in Healing Relationships 39:44 The Journey to Recovery and Long-Term Healing 43:11 How to Advocate for Yourself in Mental Health Care 46:19 Building Trust in Public Safety and Military Communities 48:22 Why We Need More Healers for Warriors 53:16 Doc Springer's Book Fallout and Its Mission 01:01:20 Why Connection and Community Save LivesGET DOCs NEW BOOK! - https://drshaunaspringer.com/books Sponsored by: TranscendUse my referral link to book a consultation for Peptide Therapyhttp://transcendcompany.com/DenyCaballeroDr. Mark Gordon & Millennium Health Centers Get the book Peptides for Health Vol.1 Medical Edition today.  Use code Phase2P for 10% off Millennium products  Available only at MillenniumHealthStore.comPRECISION WELLNESS GROUP  Use code: Security Halt Podcast 25Website: https://www.precisionwellnessgroup.com/  Security Halt Mediahttps://www.securityhaltmedia.com/ Instagram: @securityhaltX: @SecurityHaltTik Tok: @security.halt.podLinkedIn: Deny Caballero Looking for custom handmade items, military memorabilia, or laser engraving? Contact Eric Gilgenast.Instagram:https://www.instagram.com/haus_gilgenast_woodworks_main/Website: https://www.hausgilgenastwoodworks.com/SOF Heritage Designs Custom belt Buckles. Of the Regiment for the Regiment SOF-HD.Instagram: https://www.instagram.com/sofhdesigns/Support the showProduced by Security Halt Media

The following article of the Entrepreneurs industry is: “The Success Algorithm: A Roadmap for Health Innovation in Latam” by Pedro Lopez Sela, Managing Partner, FrissOn Capital.

This thoughtful dialogue with the CTO of Garner Health highlights his professional journey, lessons learned in leveraging data and AI, and strategies for building inclusive solutions. The conversation also provides guidance for upcoming and current informaticists preparing to enter a rapidly advancing field. Episode Hosts:  Dr. Leyla Warsame, ACMIO - M Health Fairview Michi Kono, Chief Technology Officer - Garner Health

Send us Fan MailIn this episode, Quint Boa, founder and CEO of Cinema, shares insights on the intersection of video production, AI, and mental health. Discover how storytelling, animation, and AI can transform mental health diagnosis, treatment, and education, along with ethical considerations and future potentials.Chapters00:00 Introduction to Quint Boa and Cinema02:46 Quint's Journey: From Entertainment to Mental Health04:44 The Power of Storytelling in Mental Health07:30 Mental Health: Historical Perspectives and Modern Challenges09:58 The Impact of COVID-19 on Mental Health12:12 The Birth of Cinema: Filling the Gap in Video Production15:00 Animation in Mental Health: A New Approach17:27 The Role of AI in Video Production19:28 The Future of AI and Its Ethical Implications28:46 The Trust Crisis in AI and Communication31:19 AI in Psychotherapy: Opportunities and Challenges33:58 The Power of Positive Thinking and Relationships36:45 Childhood Experiences and Their Impact on Adult Behavior38:36 The Intersection of Psychology and Business41:06 Cognitive Offloading and the Future of Critical Thinking42:38 The Importance of Spreading Awareness through Media52:35 all videos files for podcast.mp4 resourcesSynima Quint Boa's Podcast -  guest linksLinkedIn - https://linkedin.com/in/quintboaInstagram - https://instagram.com/quintboa keywordsAI in mental health, video production, storytelling, animation, mental health diagnosis, AI ethics, healthcare innovation, mental health education, future of AI, mental health initiatives key  topicsAI in mental health diagnosis and treatmentUse of animation and storytelling in mental healthEthical and social challenges of AI in healthcareStorytelling as therapyAI ethics and safetyCognitive behavioral therapy (CBT)Maslow's hierarchy of needsAttachment theory“This is The Wireless Way—where mobility, IoT, and innovation drive real business outcomes.” Support the showCheck out my website https://thewirelessway.net/ use the contact button to send request and feedback. 

What if we could detect 400 rare diseases in your newborn before any symptom appears?The technology exists but the US is moving fast, China is scaling rapidly, and Europe is choosing caution. Behind the science lies a global power struggle and the rules are still being written.Welcome to Pharma Minds, Mini-Series “Who controls innovation?". In this mini-series, we explore one question in two parts: who controls innovation and who actually makes it happen.Genomic medicine is no longer a promise. It is becoming our reality.But as the science advances, a global race is emerging : the United States is moving fast, China is scaling rapidly, and Europe is advancing more cautiously.In this episode, we go inside the PERIGENOMED project with Prof. Laurence Olivier-Faivre, clinical geneticist and Head of Department at Dijon University Hospital (France), one of France's most ambitious national initiatives aiming to integrate whole-genome sequencing into newborn screening.The ultimate goal? To act before symptoms appear.By detecting over 400 rare diseases in the first days of life, we can treat conditions that are treatable before irreversible damage occurs. But behind this medical breakthrough lies a complex web of ethical dilemmas, organizational challenges, and cultural differences.In this episode, we cover:◾️ The Reality of Execution : how newborn genomic screening actually works and its direct medical impact.◾️ The Ethical Minefield : managing genetic data, incidental findings, and the critical issue of family consent.◾️ The Healthcare Revolution : the massive operational shift required for hospitals and maternity wards.◾️ The Global Race : the cultural and strategic differences in genomic medicine between France, the US, the UK, and China.◾️ The Future : what lifelong genetic prevention will look like in the years to come. Three approaches. Three speeds. Who will ultimately define the rules of preventive genomic medicine?What do you think Europe should prioritize in genomic medicine: speed, ethics, or competitiveness?Let us know in the comments.

Raised in the high Himalayas, educated across 22 homes in multiple countries, and fluent in five languages , Simmi Singh was never going to follow a conventional path. She started out wanting to be a UN translator. A mentor stopped her and said: you have a voice of your own. That single conversation redirected her toward management consulting at Booz Allen and Ernst and Young, then entrepreneurship, then scaling the health vertical at Cognizant from a $10M fledgling unit into one of the company's most significant growth stories, then 15 years as a partner and global practice leader at Egon Zehnder placing boards and entire management teams for some of the most transformational companies in the world, then a secondment as Senior Advisor on Health Innovation to the U.S. Secretary of Health and Human Services, and most recently joining Blue Cross Blue Shield of Massachusetts as Chief People Officer and Executive Vice President. In this episode of Inspiring Women, host Laurie McGraw sits down with Simmi Singh to trace the through line of a brilliantly discontinuous career and pull out the lessons that only come from decades of doing it at the highest levels. They discuss: Growing up in the Himalayas surrounded by brilliant women with broken dreams, and how that shaped her hunger for agency at a time when no recipe existed for women like her Being one of 12 women in a college of 3,000 men and becoming the first female valedictorian in the institution's 100 year history What she learned scaling Cognizant's health vertical by giving away power before she had any, and why that was the most strategic move she made How she decoded great leadership by surrounding herself with human textbooks, including mentors under 30, even at 62 Why she believes women need sponsors far more than mentors, and what it actually means to be worthy of one The mistake she sees leaders making in healthcare AI right now, and the more audacious problems she believes women should be solving Simmi Singh is proof that intellectual homelessness, the restless feeling of living on the bridges between worlds, is not a liability. It is the rarest kind of preparation.

In Episode 129 of DC EKG, Joe Grogan sits down with returning guest Adam Thierer, Resident Senior Fellow for Technology and Innovation at the R Street Institute, to break down the surge of state by state AI laws and why a patchwork approach could slow innovation, especially in healthcare. Adam explains how more than a thousand state AI bills are flooding the zone, what types of “everything bills” are emerging, and why some states are trying to set national standards from Albany or Sacramento. Joe and Adam connect the federalism debate to real world health innovation, including mental health chatbots, algorithmic discrimination laws, and why compliance costs hit “little tech” hardest. They also discuss Adam's “AI Articles of Confederation” framing, the failed effort to create a federal moratorium on state AI rules, and what a better model could look like, such as regulatory inventories, learning labs, and sandbox style approaches that allow experimentation without shutting innovation down. Key link: https://www.rstreet.org/commentary/congress-should-lead-on-ai-policy-not-the-states/ In This Conversation Why state AI bills are accelerating and what is driving them “Mega measures” that try to regulate frontier models, child safety, jobs, and copyright in one bill New York and California style rulemaking with national spillover The Micron example and how permitting and lawsuits can stop progress Algorithmic discrimination laws and why healthcare gets hit hardest Mental health chatbot bans and the access and workforce tradeoffs Preemption and why Congress keeps punting Alternative models: inventories, learning labs, sandboxes, and targeted gap fixes Timestamps0:00 What is happening with state AI bills right now1:36 Adam's background and how he got into AI policy5:55 The shift from federal regulation to state action10:27 What these state bills try to regulate13:29 Micron, permitting delays, and stopping progress20:00 Why some red states are pushing AI Bills of Rights26:24 “AI Articles of Confederation” and why it matters31:01 The attempted moratorium in the “big, beautiful bill”38:03 Preview of “The AI Terrible Ten” and worst state models39:43 Mental health chatbot bans and the mental health crisis44:25 What governors should do instead of rushing to regulate49:05 What Adam is tracking next51:48 What AI tools Adam uses52:42 Where to find Adam's work SEO Keywordsstate AI laws, AI policy, federal preemption, healthcare innovation, algorithmic discrimination, mental health chatbots, interoperability, AI regulation About Our GuestAdam Thierer is a Resident Senior Fellow at the R Street Institute focused on technology and innovation policy. He writes and speaks widely on AI governance, federalism and preemption, and how regulatory models can either accelerate or stall innovation, including in healthcare. Podcast: DC EKG with Joe GroganEpisode: 129Guest: Adam Thierer, Resident Senior Fellow, Technology and Innovation, R Street InstituteSponsor: Survivors for Solutions – https://survivorsforsolutions.orgExecutive Producer: John “CZ” Czwartacki, DC EKG PodcastProducer: Julie Riga, Stay on Course Studios – https://www.stayoncourse.studio

In Episode 129 of DC EKG, Joe Grogan sits down with returning guest Adam Thierer, Resident Senior Fellow for Technology and Innovation at the R Street Institute, to break down the surge of state by state AI laws and why a patchwork approach could slow innovation, especially in healthcare. Adam explains how more than a thousand state AI bills are flooding the zone, what types of “everything bills” are emerging, and why some states are trying to set national standards from Albany or Sacramento. Joe and Adam connect the federalism debate to real world health innovation, including mental health chatbots, algorithmic discrimination laws, and why compliance costs hit “little tech” hardest. They also discuss Adam's “AI Articles of Confederation” framing, the failed effort to create a federal moratorium on state AI rules, and what a better model could look like, such as regulatory inventories, learning labs, and sandbox style approaches that allow experimentation without shutting innovation down. Key link: https://www.rstreet.org/commentary/congress-should-lead-on-ai-policy-not-the-states/ In This Conversation Why state AI bills are accelerating and what is driving them “Mega measures” that try to regulate frontier models, child safety, jobs, and copyright in one bill New York and California style rulemaking with national spillover The Micron example and how permitting and lawsuits can stop progress Algorithmic discrimination laws and why healthcare gets hit hardest Mental health chatbot bans and the access and workforce tradeoffs Preemption and why Congress keeps punting Alternative models: inventories, learning labs, sandboxes, and targeted gap fixes Timestamps0:00 What is happening with state AI bills right now1:36 Adam's background and how he got into AI policy5:55 The shift from federal regulation to state action10:27 What these state bills try to regulate13:29 Micron, permitting delays, and stopping progress20:00 Why some red states are pushing AI Bills of Rights26:24 “AI Articles of Confederation” and why it matters31:01 The attempted moratorium in the “big, beautiful bill”38:03 Preview of “The AI Terrible Ten” and worst state models39:43 Mental health chatbot bans and the mental health crisis44:25 What governors should do instead of rushing to regulate49:05 What Adam is tracking next51:48 What AI tools Adam uses52:42 Where to find Adam's work SEO Keywordsstate AI laws, AI policy, federal preemption, healthcare innovation, algorithmic discrimination, mental health chatbots, interoperability, AI regulation About Our GuestAdam Thierer is a Resident Senior Fellow at the R Street Institute focused on technology and innovation policy. He writes and speaks widely on AI governance, federalism and preemption, and how regulatory models can either accelerate or stall innovation, including in healthcare. Podcast: DC EKG with Joe GroganEpisode: 129Guest: Adam Thierer, Resident Senior Fellow, Technology and Innovation, R Street InstituteSponsor: Survivors for Solutions – https://survivorsforsolutions.orgExecutive Producer: John “CZ” Czwartacki, DC EKG PodcastProducer: Julie Riga, Stay on Course Studios – https://www.stayoncourse.studio

March 12, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Nike brings back After Dark Tour for 2026, expanding women-focused nighttime race series to seven global cities after drawing 50K+ participants Microsoft reports handling 50M+ daily health questions across Bing and Copilot, with 40% focused on symptoms and 1 in 5 involving personal health management Health Innovation Lab returns to West Palm Beach in November 2026, expanding to 250 attendees with dedicated HIL day ahead of Eudimonia Summit. Learn more at https://joinhil.com Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. A recent Nature Medicine study went viral after reporting that ChatGPT Health under-triaged more than half of emergency cases when tested using clinician-written scenarios. The finding raised serious concerns about whether consumer AI tools are safe for medical triage.But researchers from Macquarie University's Australian Institute of Health Innovation took a closer look at the study design and suspected the results might reflect the evaluation format rather than the AI's clinical capability.In this episode of Pulse Amplify, Louise and George speak with David Fraile Navarro about their follow-up study testing five frontier AI models across more than a thousand trials. Their research suggests that when AI systems are evaluated using more natural, patient-style interactions rather than exam-style prompts, triage performance improves significantly.The discussion explores why prompt structure, forced answer formats, and restrictions on clarifying questions can dramatically alter model behaviour, and why designing realistic evaluation methods is essential as millions of people begin using AI for health advice.The conversation also examines broader questions: How should AI triage tools be evaluated? What role should clinicians play in AI-mediated care? And what do patients need to know before trusting AI with health decisions?ReferencesRamaswamy A. et al. (2026). ChatGPT Health performance in a structured test of triage recommendations. Nature Medicine. https://www.nature.com/articles/s41591-026-04297-7Fraile Navarro D, Magrabi F, Coiera E. (2026). Evaluation format, not model capability, drives triage failure in the assessment of consumer Health AI. Zenodo. https://doi.org/10.5281/zenodo.18975048Connect with David Fraile Navarro: LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

On this edition of The Mark White Show, we're focusing on two major health issues affecting millions of Americans: colorectal cancer and major depressive disorder. In our first segment, Dr. James T. McCormick, DO, FACS, of the American College of Surgeons, discusses the rising rates of colorectal cancer in adults under 50. He explains which symptoms should never be ignored, why delays in diagnosis are common among younger patients, and when screening should begin. Early detection can save lives, and this conversation highlights why awareness matters at every age. In our second segment, we turn to mental health. Depression affects an estimated 21 million adults in the United States, and many individuals with Major Depressive Disorder continue to experience symptoms even while in treatment. Dr. Saundra Jain, MA, PsyD, LPC, and mental health advocate Kelly Uchima share insights into the evolving treatment landscape, the importance of integrated care, and how emerging, technology-supported tools are designed to complement traditional approaches. Listen & share. It could save someone's life.

Reflections on the Peter Attia/Epstein scandal; How to lower lp(a)—does diet help? What are bio-active peptides? Could they stave off kidney disease? Scientists just tested the fittest 81-year-old in the world—here's what they found; Media erroneously report that intermittent fasting is not effective for weight loss; Sugary drinks may stoke anxiety in teens; Omega-3s support kids' reading fluency and spelling scores; Surprising study shows saturated fats not harmful to kidneys.

In this episode of Portfolio Pulse, host Steven Huskey sits down with Mark Young, Acting CEO of Zona Health, to explore an entrepreneurial journey that took an unexpected turn into cardiovascular innovation. What began as a short-term consulting role evolved into a seven-year mission leading FDA clinical trials and reshaping how we think about heart health. Mark shares how his background in marketing, education, and entrepreneurship uniquely positioned him to lead a health technology company, why entrepreneurs often neglect their health, and how focusing on root causes—both in business and wellness—can prevent crises before they happen. A candid conversation on saying yes, figuring it out, and building success without sacrificing health along the way.

Rebuilding Research: Lowering Barriers and Rethinking Evidence in Health Innovation On this episode, host Erica Olenski interviews Zeenia Framroze, CEO and Founder of Alethios, a company on a mission to democratize health research. They explore how AI, decentralized models, and smarter evidence generation can solve persistent challenges in clinical trials, including cost, access, and complexity. From shifting away from the traditional pharma model to creating a more participatory approach to research, Zeenia shares what it takes to build a future where better questions lead to better health outcomes. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, we hear how Generative AI is making it into the consultation room - but not through NHS endorsed routes - surveys suggest that ⅔ of doctors are using AI, for backoffice tasks - but also increasingly for information and diagnosis.   David Navarro, a research fellow in generative AI at the Australian Institute of Health Innovation, Charlotte Blease, associate professor at the Participatory eHealth and Health Data Research Group at Uppsala University, and Marcus Lewis, GP in London, reflect on what we know about the real way in gen AI is being used - and what “triadic care” (doctor, patient and AI) will mean for the future of the therapeutic relationship.   We also hear from Teppo Järvinen, professor of orthopaedic surgery at Helsinki University, about surgical subacromial decompression - a 10 year follow up of a double blinded placebo controlled trial, confirms that surgery is no more effective than standard care. Yet surgical interventions continue - we hear why.   Finally, we go to a Cholera clinic in Nigeria, where Médecins Sans Frontières are running cholera treatment centres, which you can help by donating to our Christmas appeal.   Links Generative AI and the clinical encounter   The BMJ appeal 2025-26: Inside MSF's response to cholera in Nigeria: a day in the life of an emergency doctor   Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome

In this episode, Dr. Maulik Purohit, Chief Health Innovation Officer at datosX Digital Health Labs, joins Scott Becker to discuss the challenges health systems face in evaluating digital health solutions. From determining the right testing period to ensuring successful implementation, Dr. Purohit shares insights on how organizations can make strategic decisions about adopting and sustaining new technologies in an increasingly complex healthcare landscape.

Dr. Ralph Ford, chancellor of Penn State Behrend, talks with Dr. Will Walker, director of the college's Women's Health Innovation and Science Translational Lab, about how Behrend's role in the MWRI-Erie initiative is helping to benefit medical research, undergraduate learning experiences, and the broader Erie community. Originally recorded on November 14, 2025.

On this episode, Alex explores the role of synthetic data in health care and life sciences with Harry Keen, Co-Founder of Hazy, and Dr. Mark Lambrecht, Global Head of Health and Life Sciences Advisory at SAS. The conversation explores practical use cases for synthetic data in the health ecosystem as well as important limitations and considerations for ensuring security and governance.A core challenge for all health and life sciences organizations is the fragmented and decentralized nature of their data. Keen and Dr. Lambrecht agree that synthetic data can be used to remove barriers, improve efficiency and test approaches to extract more value from existing data, thereby driving innovation and enhancing patient outcomes. Tune in to hear their advice for all leaders interested in building or growing the utility of synthetic data for their organizations.

The dystopian futuristic movie Elysium portrays a terrible future in which only the rich have medical care while the poor suffer on an overpopulated, polluted planet. The film's theme—that only huge wealth transfers can bring medical care to low-income people—is fundamentally flawed.Original article: https://mises.org/mises-wire/dystopia-misdiagnosed-how-rich-drive-health-innovation

The dystopian futuristic movie Elysium portrays a terrible future in which only the rich have medical care while the poor suffer on an overpopulated, polluted planet. The film's theme—that only huge wealth transfers can bring medical care to low-income people—is fundamentally flawed.Original article: https://mises.org/mises-wire/dystopia-misdiagnosed-how-rich-drive-health-innovation

Send us a textCould exercise be just what the doctor ordered for recovery during chemotherapy? In this episode of “The UMB Pulse,” explore this novel approach to cancer recovery with Ian Kleckner, PhD, MPH, associate professor at the University of Maryland School of Nursing and director of the SYNAPSE Center. Kleckner shares how exercise can alleviate symptoms of chemotherapy-induced peripheral neuropathy and improve the quality of life for cancer survivors. Through his research, Kleckner investigates how movement can reduce inflammation, enhance brain and body coordination, and empower patients to reclaim their lives. Chapter Markers 00:00 – Introduction 00:00:17 – Cancer Treatment & Neuropathy 00:01:37 – Guest Introduction: Dr. Ian Kleckner 00:05:06 – Understanding Neuropathy 00:09:38 – Research Findings: Brain & Exercise 00:13:33 – Exercise Intervention & Clinical Trials 00:19:08 – Practical Advice & Takeaways 00:23:31 – Conclusion & CreditsListen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

Dr. Hoffman continues his conversation with Marina Pavlovic Rivas, co-founder and CEO of Eli Health.

Marina Pavlovic Rivas, co-founder and CEO of Eli Health, reveals a revolution in personal health monitoring through advanced wearable devices. They discuss the journey from primitive step counters to sophisticated devices, such as continuous glucose monitors (CGMs) and the world's first instant hormone monitoring system by Eli Health. The conversation delves into the new cortisol testing kit from Eli Health, exploring its implications for understanding stress, sleep, metabolism, and overall health. Rivas explains the process of using the device, its integration with a smartphone, and how AI helps interpret the hormone data for actionable insights. Future plans for Eli Health's hormone monitoring technology, including progesterone and testosterone, are also discussed, offering a glimpse into the evolving landscape of self-monitoring and personalized health.

The next decade of mental health innovation won't be defined by who builds the best product, but by who anticipates the policy pathways that bring it to scale. In this episode, Kacie Kelly, Chief Innovation Officer at Meadows Mental Health Policy Institute, explores how behavioral health startups can bridge the gap between early traction and national scalability by viewing policy as a strategic growth tool rather than merely a compliance requirement. She reflects on a recent Washington, DC, event that united over 60 tech and policy leaders to tackle barriers to scaling tech-enabled, measurement-informed care. The discussion spanned topics such as AI in mental health, workforce trust in technology, and the importance of constructive dialogue between innovators and policymakers. Kacie highlights that policy determines who pays for what, when, and how, urging founders to build reimbursement strategies early and leverage programs like HeadsUp to navigate policy landscapes and accelerate growth through federal initiatives. Tune in and learn how policy foresight can become your most powerful innovation advantage! Resources: Connect with and follow Kacie Kelly on LinkedIn. Follow the Meadows Mental Health Policy Institute on LinkedIn and visit their website. Listen to Kacie Kelly and Talisha Searcy's previous interview on our podcast here. Learn more about the HeadsUp service here.

Doug sits down with Dr. Victor Carsrud, Head of Functional Medicine & Health Innovation at Breather Mae, to map a no-fluff health playbook for high-demand performers—rodeo athletes, ranchers, farmers, and anyone who works hard. We dig into why "test, don't guess" matters, how a simple Gut Check unlocks better hormone balance and recovery, and the panels most annual physicals miss (full thyroid with antibodies, prolactin for pituitary stress, micronutrients, organic acids). We also get real on environmental toxins (mold, microplastics, PFAS), what to eat on the road, and why 30g protein within 30 minutes of waking changes your day. What you'll learn Why TSH alone isn't enough: add Free T3/T4 + TPO/TG antibodies How gut → brain → hormones all connect (and why it's step one) When prolactin flags pituitary stress (think head hits/endocrine disruptors) "Test don't guess" supplements (yes, vitamin D can be too high) Tiered testing: Baseline → Tier 1/2 → Tier 3 → Olympiad Real-world fueling for the road: protein-first wins for energy & focus. Chapters 00:00 Intro & access-anywhere functional medicine 02:15 What basic labs miss (TSH ≠ full thyroid picture) 08:40 Coaching model: from "doctor knows best" to partnership 10:45 Gut ↔ brain ↔ hormones—no more silos 15:00 You can't out-supplement bad data 21:00 Why proactive labs matter in dangerous sports & work 27:10 Low T in roughstock? Stress, sleep, hits & gut links 28:20 Breather Mae tiers (Baseline → Olympiad) 49:30 Protein timing: the 30/30 rule 54:00 Recovery & oxidative stress markers 59:00 Making 80-page labs actionable (not pill-pushing) 1:03:00 Pricing, installments, and ROI for athletes Brought to you by our partners:

In this Mission Matters episode, ⁠Adam Torres⁠ interviews ⁠Lindsay Davis⁠, Founder of FemTech Association Asia, about leading Asia's growing femtech ecosystem. Davis shares how the association connects 80+ startups across 10 countries, fostering innovation and collaboration in women's health, advocacy, and technology. Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

Assistant Secretary for Technology Policy Chief of Innovation and Strategic Partnerships Stephen Konya has been credited with launching groundbreaking initiatives like CancerX to accelerate innovation in health care. These efforts are largely borne out of partnerships with the private sector, including academia, entrepreneurs, investors, developers and more. Konya shared how he's building innovation ecosystems that stay rooted in patient needs while advancing cutting-edge technologies. He highlighted how connecting innovation networks to resources can also expand patient access to care. Drawing on his experience leading Federal Innovation Days and spearheading interagency collaborations, Konya offered lessons on translating federal innovation into real-world impact. He also explored the biggest barriers to access, strategies for sustaining innovation and the emerging technologies shaping the future of health care.

Dr. Maulik Purohit, Chief Health Innovation Officer at datosX Digital Health Labs, explores global governance in the realm of AI safety and responsibility. He discusses the challenges of improving access to responsible AI and the importance of developing ethical frameworks that guide innovation in healthcare technology.

Even privilege can't guarantee success in women's health innovation. In this episode of Black Women's Health Podcast, Dr. Rahman , board certified OB/GYN looks at why so many women's health startups fail - even when backed by money, influence and access.Inspired by Veronica Adamson"s STAT news article, "Why Promising Women's Health Companies Die So Often", this episodes looks at poor reimbursement models, regulatory roadblocks and a healthcare system that continues to undervalue women's bodies and experienc

Episode SummaryWomen's health faces systemic challenges that too often leave women without answers — especially in midlife, when care becomes fragmented and reimbursement models make solutions hard to scale.In this episode of Fempower Health, Georgie Kovacs speaks with Joanna Strober, CEO and co-founder of Midi Health and a seasoned entrepreneur who previously founded Kurbo Health (acquired by Weight Watchers). Joanna shares her journey from personal struggles with perimenopause symptoms to building solutions that confront the structural barriers in women's health.Together, we explore why women are left to self-navigate, how venture capital and philanthropy are shaping the field, and what it will take to close the gap between research and real-world care.If you're a woman seeking answers about your health, or a clinician striving to better serve your patients, this episode will give you a candid look at the truth: the system isn't designed for women — but with insight and bold action, change is possible.Discussion PointsWhy do midlife women often “fall out” of the healthcare system?How do insurance and reimbursement barriers prevent women-centered care from scaling?Why does it take an average of 17 years for clinical evidence to become standard practice?How should innovators responsibly use emerging research in women's health?What role did Pivotal Ventures and Wellcome Trust's $100M commitment play — and why isn't it enough?How do venture capital investors view women's health innovation — is it bias, or a need to show scale?What cultural factors lead women to tolerate suffering instead of pushing for better care?Where does Joanna Strober see hope for the future of women's health innovation?

The Department of Health and Human Services (HHS) is transforming how health data is shared and used, emphasizing transparency. Chief Data Officer Kristen Honey is spearheading an “open by default” strategy that moves away from top-down, siloed data management to a more collaborative model. HHS is pushing decision-making to local, state and regional experts on the front lines of public health. Inspired by rapid response strategies used during the COVID-19 pandemic, the updated plan takes a modular, flexible format housed on open platforms like GitHub. This allows external partners to provide feedback and co-create solutions that accelerate innovation. At the same time, the refreshed HealthData.gov serves as a one-stop shop for navigating HHS's massive data ecosystem, with AI-driven tools designed to improve usability and responsiveness. HHS is fostering partnerships across government, industry and academia to drive external innovation while ensuring solutions meet authoritative federal standards.

Dr. Jeffrey Bland, a pioneer in the field of integrative and functional medicine, discusses his latest project, Big Bold Health, which focuses on immune system rejuvenation through natural products like HTB (Himalayan Tery Buckwheat) and high-quality fish oil. The conversation delves into the origins and benefits of functional medicine, the importance of diet and lifestyle in health, and the concept of making America healthy. Dr. Bland also shares insights into his journey and the influence of traditional medicine practices. Listeners are encouraged to explore more about functional medicine and Big Bold Health's unique offerings.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Investing in care infrastructure and mental health access is not just compassionate, it's foundational to long-term systemic change. In this episode, Brittney Riley Gavini, the Director of Investments at Pivotal Ventures, discusses how targeted investment strategies are unlocking real progress in youth mental health, family care, and women's empowerment. She explains how her career evolved from startups to mission-driven venture capital, and how her team supports both philanthropic and for-profit initiatives that close care gaps. Brittney highlights investments in innovative companies and shares the importance of funding diverse founders and fund managers to reshape the innovation pipeline, especially in mental health and financial access. She also acknowledges challenges in youth mental health startups like provider shortages and complex engagement pathways. Lastly, Brittney offers advice for startups pitching investors: make it a meaningful, generative conversation, not just a transaction. Tune in and learn how mission-aligned investing is reshaping behavioral health, one bold bet at a time! Resources: Connect with and follow Brittney Riley Gavini on LinkedIn. Follow Pivotal Ventures on LinkedIn and explore their website.